Biomiga, Inc.

Biomiga, Inc. is a San Diego-based biotech research and manufacturing company specializing in nucleic acid extraction, purification, and PCR-based diagnostic products. Core product lines include the MgPure family of automated DNA/RNA extraction kits designed for diverse sample types: pathogenic, blood, saliva, circulating cell-free DNA, and formalin-fixed paraffin-embedded (FFPE) tissue. The company manufactures DNA/RNA size-selection beads offering superior yield (10–20% better than benchmarks) at competitive pricing, with full USA manufacturing and OEM customization capability. MgPure Seq DTR beads support sequencing workflows with >800 bp average reading lengths, available in manual or automated formats compatible with major platforms (Kingfisher Flex, Biomek, Hamilton, and others). Biomiga offers comprehensive real-time PCR detection assays targeting infectious disease panels, including respiratory pathogen panels (RPP), sexually transmitted infections (STI), gastrointestinal pathogens, women's health, wound infection markers, and nail fungal detection. The company also provides customized services for gene synthesis, cell line construction, protein expression, lentivirus packaging, and next-generation sequencing. FDA-registered facility with ISO 9001:2015 certification. All extraction protocols are fully validated for automation on industry-standard platforms. The company emphasizes in-house manufacturing control, 24/7 customer support, and R&D-driven product development.